159 related articles for article (PubMed ID: 37802683)
1. Novel Use of Circulating Tumor DNA to Identify Muscle-invasive and Non-organ-confined Upper Tract Urothelial Carcinoma.
Huelster HL; Gould B; Schiftan EA; Camperlengo L; Davaro F; Rose KM; Soupir AC; Jia S; Zheng T; Sexton WJ; Pow-Sang J; Spiess PE; Daniel Grass G; Wang L; Wang X; Vosoughi A; Necchi A; Meeks JJ; Faltas BM; Du P; Li R
Eur Urol; 2024 Mar; 85(3):283-292. PubMed ID: 37802683
[TBL] [Abstract][Full Text] [Related]
2. Perioperative circulating tumor DNA enables the identification of patients with poor prognosis in upper tract urothelial carcinoma.
Nakano K; Koh Y; Yamamichi G; Yumiba S; Tomiyama E; Matsushita M; Hayashi Y; Wang C; Ishizuya Y; Yamamoto Y; Kato T; Hatano K; Kawashima A; Ujike T; Fujita K; Kiyotani K; Katayama K; Yamaguchi R; Imoto S; Imamura R; Nonomura N; Uemura M
Cancer Sci; 2022 May; 113(5):1830-1842. PubMed ID: 35293110
[TBL] [Abstract][Full Text] [Related]
3. Postoperative recurrence detection using individualized circulating tumor DNA in upper tract urothelial carcinoma.
Tamura D; Abe M; Hiraki H; Sasaki N; Yashima-Abo A; Ikarashi D; Kato R; Kato Y; Maekawa S; Kanehira M; Takata R; Maejima K; Sasagawa S; Fujita M; Suzuki Y; Nakagawa H; Iwaya T; Nishizuka SS; Obara W
Cancer Sci; 2024 Feb; 115(2):529-539. PubMed ID: 38083992
[TBL] [Abstract][Full Text] [Related]
4. Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma.
Messer JC; Terrell JD; Herman MP; Ng CK; Scherr DS; Scoll B; Boorjian SA; Uzzo RG; Wille M; Eggener SE; Lucas SM; Lotan Y; Shariat SF; Raman JD
Urol Oncol; 2013 Aug; 31(6):904-8. PubMed ID: 21906967
[TBL] [Abstract][Full Text] [Related]
5. Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients.
Grasso M; Fishman AI; Cohen J; Alexander B
BJU Int; 2012 Dec; 110(11):1618-26. PubMed ID: 22458598
[TBL] [Abstract][Full Text] [Related]
6. Nephroureterectomy vs. segmental ureterectomy of clinically localized, high-grade, urothelial carcinoma of the ureter: Practice patterns and outcomes.
Piraino JA; Snow ZA; Edwards DC; Hager S; McGreen BH; Diorio GJ
Urol Oncol; 2020 Nov; 38(11):851.e1-851.e10. PubMed ID: 32859461
[TBL] [Abstract][Full Text] [Related]
7. Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma.
Favaretto RL; Shariat SF; Savage C; Godoy G; Chade DC; Kaag M; Bochner BH; Coleman J; Dalbagni G
BJU Int; 2012 Jan; 109(1):77-82. PubMed ID: 21631698
[TBL] [Abstract][Full Text] [Related]
8. Patient-specific targeted analysis of circulating tumour DNA in plasma is feasible and may be a potential biomarker in UTUC.
Mu N; Jylhä C; Axelsson T; Sydén F; Brehmer M; Tham E
World J Urol; 2023 Dec; 41(12):3421-3427. PubMed ID: 37721600
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
10. Upper Urinary Tract Urothelial Cancer After Radical Cystectomy for Bladder Cancer: Survival Outcomes After Radical Nephroureterectomy.
Ślusarczyk A; Zapała P; Piecha T; Zapała Ł; Borkowski T; Radziszewski P
Ann Surg Oncol; 2024 Mar; 31(3):2144-2153. PubMed ID: 38085392
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of the systemic inflammation modified Glasgow prognostic score in patients with upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy: Results from a large multicenter international collaboration.
Soria F; Giordano A; D'Andrea D; Moschini M; Rouprêt M; Margulis V; Karakiewicz PI; Briganti A; Bensalah K; Mathieu R; Chlosta P; Babjuk M; Glybochko PV; Enikeev DV; Remzi M; Gust K; Gontero P; Shariat SF
Urol Oncol; 2020 Jun; 38(6):602.e11-602.e19. PubMed ID: 32037197
[TBL] [Abstract][Full Text] [Related]
12. Genomic Characterization of Upper Tract Urothelial Carcinoma.
Sfakianos JP; Cha EK; Iyer G; Scott SN; Zabor EC; Shah RH; Ren Q; Bagrodia A; Kim PH; Hakimi AA; Ostrovnaya I; Ramirez R; Hanrahan AJ; Desai NB; Sun A; Pinciroli P; Rosenberg JE; Dalbagni G; Schultz N; Bajorin DF; Reuter VE; Berger MF; Bochner BH; Al-Ahmadie HA; Solit DB; Coleman JA
Eur Urol; 2015 Dec; 68(6):970-7. PubMed ID: 26278805
[TBL] [Abstract][Full Text] [Related]
13. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.
Seisen T; Peyronnet B; Dominguez-Escrig JL; Bruins HM; Yuan CY; Babjuk M; Böhle A; Burger M; Compérat EM; Cowan NC; Kaasinen E; Palou J; van Rhijn BW; Sylvester RJ; Zigeuner R; Shariat SF; Rouprêt M
Eur Urol; 2016 Dec; 70(6):1052-1068. PubMed ID: 27477528
[TBL] [Abstract][Full Text] [Related]
14. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.
Cutress ML; Stewart GD; Wells-Cole S; Phipps S; Thomas BG; Tolley DA
BJU Int; 2012 Dec; 110(11):1608-17. PubMed ID: 22564677
[TBL] [Abstract][Full Text] [Related]
15. The long-term outcome of nephron-sparing surgery versus radical nephroureterectomy for organ-localized upper urinary tract urothelial carcinoma: a population-based study of 1969 patients.
Qiu J; Deng R; Yu C; Gong K
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14869-14878. PubMed ID: 37598342
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Liquid-Biopsy-Based Biomarkers in Upper Tract Urothelial Carcinoma.
Padullés B; Carrasco R; Ingelmo-Torres M; Roldán FL; Gómez A; Vélez E; Alfambra H; Figueras M; Carrion A; Gil-Vernet J; Mengual L; Izquierdo L; Alcaraz A
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612507
[TBL] [Abstract][Full Text] [Related]
17. Prognostic models for upper urinary tract urothelial carcinoma patients after radical nephroureterectomy based on a novel systemic immune-inflammation score with machine learning.
Liu J; Wu P; Lai S; Wang J; Hou H; Zhang Y
BMC Cancer; 2023 Jun; 23(1):574. PubMed ID: 37349696
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of plasma fibrinogen levels in patients with localized upper tract urothelial carcinoma.
Tanaka N; Kikuchi E; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakamura S; Oya M
BJU Int; 2013 May; 111(6):857-64. PubMed ID: 22757942
[TBL] [Abstract][Full Text] [Related]
19. Incidence and Survival Rates of Contemporary Patients with Invasive Upper Tract Urothelial Carcinoma.
Collà Ruvolo C; Nocera L; Stolzenbach LF; Wenzel M; Cucchiara V; Tian Z; Shariat SF; Saad F; Longo N; Montorsi F; Briganti A; Mirone V; Karakiewicz PI
Eur Urol Oncol; 2021 Oct; 4(5):792-801. PubMed ID: 33293235
[TBL] [Abstract][Full Text] [Related]
20. Clinical Utility of Cell-free and Circulating Tumor DNA in Kidney and Bladder Cancer: A Critical Review of Current Literature.
Green EA; Li R; Albiges L; Choueiri TK; Freedman M; Pal S; Dyrskjøt L; Kamat AM
Eur Urol Oncol; 2021 Dec; 4(6):893-903. PubMed ID: 33975782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
